{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:32:53Z","timestamp":1791340373527,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2019-I2M-5-046"],"award-info":[{"award-number":["2019-I2M-5-046"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.amjms.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T11:00:22Z","timestamp":1634814022000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and Pathological Features of Renal Presentations in Polycythemia Vera"],"prefix":"10.1016","volume":"363","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2021.10.009_bib0001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bjh.15648","article-title":"A guideline for the diagnosis and management of polycythaemia vera. A British society for haematology guideline","volume":"184","author":"McMullin","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0002","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.amjms.2021.10.009_bib0003","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2021.10.009_bib0004","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/leu.2010.148","article-title":"A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications","volume":"24","author":"Passamonti","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.amjms.2021.10.009_bib0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjms.2021.10.009_bib0006","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ndt\/12.1.212","article-title":"IgA nephropathy associated with polycythaemia vera: accelerated course","volume":"12","author":"Kasuno","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjms.2021.10.009_bib0007","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000409764","article-title":"Pathologic conditions associated with IgA mesangial nephropathy: preliminary results","volume":"40","author":"Makdassy","year":"1984","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000065236","article-title":"IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria","volume":"22","author":"Chung","year":"2002","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0009","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/etm.2015.2572","article-title":"Polycythemia vera associated with IgA nephropathy: A case report and literature review","volume":"10","author":"Chen","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjms.2021.10.009_bib0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjms.2021.10.009_bib0011","first-page":"70","article-title":"Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era","volume":"24","author":"Del Sordo","year":"2017","journal-title":"Clin Nephrol Case Stud"},{"key":"10.1016\/j.amjms.2021.10.009_bib0012","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.amjms.2021.10.009_bib0013","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12185-020-02898-7","article-title":"kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia cera","volume":"112","author":"Krecak","year":"2020","journal-title":"Int Hematol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0014","series-title":"Atlas of nontumor pathology: non-neoplastic kidney diseases","first-page":"269","author":"D'Agati","year":"2005"},{"key":"10.1016\/j.amjms.2021.10.009_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjms.2016.12.019","article-title":"Risk factors for severe bleeding complications in percutaneous renal biopsy","volume":"353","author":"Xu","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjms.2021.10.009_bib0016","unstructured":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms.Histopathology 2020 Oct 20"},{"key":"10.1016\/j.amjms.2021.10.009_bib0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.blre.2014.12.002","article-title":"Mechanisms of thrombogenesis in polycythemia vera","volume":"29","author":"Kroll","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.amjms.2021.10.009_bib0018","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmoldx.2013.07.002","article-title":"Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the association for molecular pathology","volume":"15","author":"Gong","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.amjms.2021.10.009_bib0019","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2006-10-054940","article-title":"The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera","volume":"110","author":"Dupont","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2021.10.009_bib0020","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.leu.2404724","article-title":"Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera","volume":"21","author":"Tefferi","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.amjms.2021.10.009_bib0021","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/sj.leu.2404854","article-title":"Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden","volume":"21","author":"Vannucchi","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.amjms.2021.10.009_bib0022","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2021.10.009_bib0023","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood-2012-07-440487","article-title":"JAK2V617F activates Lu\/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1\/Akt pathway","volume":"121","author":"De Grandis","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2021.10.009_bib0024","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood-2013-06-501452","article-title":"JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia","volume":"122","author":"Hobbs","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.amjms.2021.10.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020003614","article-title":"Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis","volume":"55","author":"Rontauroli","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.amjms.2021.10.009_bib0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0272-6386(12)80971-1","article-title":"Mechanisms of progressive renal disease in glomerulonephritis","volume":"23","author":"Couser","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjms.2021.10.009_bib0027","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2010.07.032","article-title":"Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy","volume":"399","author":"Tokunaga","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.amjms.2021.10.009_bib0028","article-title":"Quantification of IGF-1 receptor may be useful in diagnosing polycythemia vera-suggestion to be added to be one of the minor criterion","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2021.10.009_bib0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000188311","article-title":"Differential effects of insulin-like growth factor I and platelet-derived growth factor on growth response, matrix formation, and cytosolic free calcium of glomerular mesangial cells of spontaneously hypertensive and normotensive rats","volume":"68","author":"Heidenreich","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.amjms.2021.10.009_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000025863","article-title":"Cloning of a human renal p-aminohippurate transporter, hROAT1","volume":"21","author":"Reid","year":"1998","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjms.2021.10.009_bib0031","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12882-019-1626-1","article-title":"Delayed diagnosis of acromegaly in a patient with focal segmental glomerulosclerosis: a rare case report and literature review","volume":"20","author":"Zheng","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0032","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1159\/000481970","article-title":"Urinary erythrocyte-derived mirnas: emerging role in IgA nephropathy","volume":"42","author":"Duan","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjms.2021.10.009_bib0033","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000168463","article-title":"Abnormal regulation of insulin-like growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy","volume":"12","author":"Nakamura","year":"1992","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000486914","article-title":"Rs1520220 and Rs2195239 polymorphisms of IGF-1 gene associated with histopathological grades in IgA nephropathy in Northwestern Chinese han population","volume":"43","author":"Wei","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.amjms.2021.10.009_bib0035","first-page":"212","article-title":"Activated peripheral blood mononuclear cells in IgA nephropathy express platelet-derived growth factor B-chain messenger RNA","volume":"120","author":"Nakamura","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjms.2021.10.009_bib0036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","article-title":"A new look at platelet-derived growth factor in renal disease","volume":"19","author":"Floege","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjms.2021.10.009_bib0037","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI114759","article-title":"Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells","volume":"86","author":"Kourembanas","year":"1990","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.amjms.2021.10.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2019000655","article-title":"Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms","volume":"3","author":"Hong","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.amjms.2021.10.009_bib0039","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","article-title":"Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis","volume":"124","author":"Tefferi","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.amjms.2021.10.009_bib0040","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1200\/JCO.2012.42.1925","article-title":"Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008:a populationbased study","volume":"30","author":"Hultcrantz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.amjms.2021.10.009_bib0041","doi-asserted-by":"crossref","DOI":"10.1080\/10428194.2017.1312380","article-title":"The presence of monoclonal gammopathy in phnegative myeloproliferative neoplasms is associated with a detrimental effect on outcomes","volume":"58","author":"Le Clech","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.amjms.2021.10.009_bib0042","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1055\/s-0038-1657600","article-title":"Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD)","volume":"78","author":"Murphy","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjms.2021.10.009_bib0043","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000188667","article-title":"Acute effect of human recombinant insulin-like growth factor I on renal function in humans","volume":"71","author":"Giordano","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.amjms.2021.10.009_bib0044","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.ajkd.2016.02.056","article-title":"Hydroxyurea for treatment of nephrotic syndrome associated with polycythemia vera","volume":"68","author":"Hundemer","year":"2016","journal-title":"Am J Kidney Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921003700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921003700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:08Z","timestamp":1762082168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921003700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0002962921003700"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.10.009","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Pathological Features of Renal Presentations in Polycythemia Vera","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}